Brain Mind & Memory Institute

27/05/2026

Two patients. One diagnosis. Two completely different brains.

One of the key points I address in our recent publication is the heterogeneity of psychiatric disorders. Take Depression, for example. Two patients can meet the exact same clinical criteria for MDD, yet their qEEG maps might show:

1. One with significant frontal alpha asymmetry.
2. Another with diffuse high-beta activity.

These are two different biological states masquerading as the same "label."

If we treat them the same way, one will likely fail the intervention. My paper explores how using qEEG to identify these specific phenotypes allows us to bypass the "trial-and-error" phase and get straight to the intervention that matches the patient's biology.

Read the full review 👇️

14/05/2026

12/05/2026

What happened to clinical EEG interpretation?
And how did psychiatry and neurology become so disconnected from the very brain signals they once relied upon?

At the 2026 ANSA Conference, internationally respected EEG expert Jay Gunkelman will present a provocative and important session:

“DSM-5 and Current Clinical EEG Interpretation: How Did We Get This Screwed Up?”

Jay will discuss the evolution of our current clinical landscape — where psychiatry increasingly relied on DSM categorisation while neurology narrowed EEG interpretation to epilepsy and overt encephalopathies, often ignoring broader psychiatric relevance.

The presentation explores:
• The evolution of the DSM from I to V
• The decline of classical clinical EEG interpretation
• The loss of clinically meaningful EEG patterns into categories such as “non-specific,” “normal variants,” or “controversial findings”
• The split between modern computational EEG analysis and traditional waveform interpretation
• The forgotten clinical richness found in the work of Gibbs & Gibbs and John Hughes

This rigid diagnostic approach, despite offering little predictive validity, fundamentally changed how clinicians are allowed to think and speak about EEG findings in psychiatry.

Jay brings a rare historical and clinical perspective to this discussion.

Starting in 1972 with one of the first State Hospital-based biofeedback laboratories, Jay has spent decades specialising in EEG and qEEG. He is regarded as one of the world’s most experienced clinical and research EEG specialists, authoring numerous scientific papers and books while lecturing internationally for decades. His contribution to clinical EEG interpretation, neurofeedback, and brain mapping has influenced practitioners worldwide.

For clinicians, neurofeedback practitioners, psychologists, psychiatrists, and researchers interested in the future of brain-based diagnostics — this is a presentation not to miss.

ANSA 2026 Conference
Neurotherapy Across the Lifespan

For more information please visit https://appliedneuroscience.org.au/2026_ANSA_Conference

26/04/2026

ADHD and the Dopamine Hypothesis — time to rethink

A recent paper in Frontiers in Psychiatry revisits one of the most widely accepted ideas in mental health — that ADHD is simply a “dopamine deficiency.”

The conclusion is quite clear. Dopamine is involved, but ADHD cannot be reduced to a simple low dopamine state.

What we are likely dealing with is a much more complex picture:
dynamic regulation of brain systems, network-level differences, developmental factors, and individual variability that cannot be captured by a single neurotransmitter model.

This has important clinical implications.

For decades, the field has been guided by a very simple assumption:
chemical imbalance can be corrected with medication.

However, real-world experience tells a different story.
Side effects are common. Long-term compliance is often low. Outcomes vary significantly from person to person.

If ADHD were truly just a chemical deficiency, we would expect far more consistent results from a purely chemical intervention.

This is where the shift is happening.

ADHD is better understood as a disorder of brain regulation rather than a static chemical imbalance.

This opens the door to more precise and biologically grounded approaches:
EEG and ERP neuromarkers, neurofeedback, photobiomodulation, and integrated, personalised interventions.

The key question for the field is no longer how to correct a deficit, but how to restore regulation in a living, dynamic system.

A critical review of the evidence

24/04/2026

Clinical evidence and mechanisms

18/04/2026

Brain Mind & Memory Institute will be a sponsor of ANSA 2026 conference on the Gold Coast. Come and see brain health technologies that change lives through neuromodulation and Neurostimulation .

Early bird tickets are now available. See details below

Early bird tickets are now available for the ANSA Conference 2026.

Members have their discounted rate tickets.

For non-members the best value option includes your conference ticket plus 12 months of ANSA membership, extending through to June 2027.

Join a growing community of practitioners, clinicians, and those interested in the research and application of applied neuroscience.

Follow the link to learn more. https://appliedneuroscience.org.au/2026_ANSA_Conference

01/04/2026

A breakthrough in brain-state detection from Max Planck Institute for Biological Cybernetics reveals a major advancement in how we measure and classify neural activity.

Researchers developed a new computational framework that improves how brain states are detected using non-invasive functional near infrared spectroscopy (fNIRS).

The team captured complementary signals produced by oxygenated and deoxygenated blood and classified mental tasks with improved accuracy: https://bit.ly/4sfgqp5

28/01/2026

URGENT REMINDER!!!!!

BrainSignals 2026 QEEG Mentoring groiup meetings with Jay Gunkelman, QEEG Diplomate, Emeritus are starting nextweek.

We are offering clinicians and researchers a unique learning experience with one of the most experienced minds in the field of quantitative EEG analysis. Despite being semi-retired, Jay continues to generously share insights gained from decades of work and analysis of hundreds of thousands of EEGs. Participants will deepen their practical skills in EEG interpretation and brain diagnostics in a collaborative environment that emphasizes case-based learning and meaningful signal analysis.

The first meeting is schedule next week:

Friday January 30, 15:00-17:00pm US Pacific time or Saturday 31st 10:00-12:00 am (Sydney time) AEDT

You can register for a single meeting on January 31, 2026, here: https://www.braininstitute.com.au/event-6525805

Or register for the block of 10 Grand Rounds here: https://www.braininstitute.com.au/event-6477172

We are looking forward to continuing to learn QEEG — and so much more —from our amazing mentor, Jay Gunkelman